(Q46613243)

23 December 2017

title

High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats (English)

1 reference

23 December 2017

1 reference

Paul J Thornalley

5

0 references

author name string

Nikolaos Karachalias

1

1 reference

23 December 2017

Roya Babaei-Jadidi

2

1 reference

23 December 2017

Christian Kupich

3

1 reference

23 December 2017

Naila Ahmed

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

23 December 2017

Annals of the New York Academy of Sciences

published in

1 reference

23 December 2017

volume

1043

1 reference

23 December 2017

page(s)

777-783

1 reference

23 December 2017

The genetics of atherothrombotic disorders: a clinician's view

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

Protein modification by advanced Maillard adducts can be modulated by dietary polyunsaturated fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.090

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1333.090

1 reference

23 December 2017

1 reference

23 December 2017